리스페리돈과 올란자핀이 투여된 정신과 환자들에서 간 효소 변화에 대한 후향적 연구

• 영문명: Retrospective Study on Hepatic Enzyme Changes in Patients Treated with Risperidone and Olanzapine
• 발행기관: 대한신경정신의학회
• 저자명: 임현국 배치운 박석준 김정진 이창욱 이수정 이철 백인호
• 간행물 정보: 『신경정신의학』제43권 제3호, 283~287쪽, 전체 5쪽
• 주제분류: 의약학 > 정신과학
• 파일형태: PDF
• 발행일자: 2004.05.30

영문 초록

Objectives：Hetapic dynfunction caused by the use of atypical antipsychotics in patients with psychiatric disorders has not been frequently reported compared to the use of typical antipsychotics. This retrospective study was aimed at assessing the differences of hepatic dysfunctions between patients treated with risperidone and olanzapine through reviewing computerizedmedical records. Methods：Charts of 667 risperidone- and olanzapin treated patients hospitalized at the department of psychiatray, Kangnam St. Mary’s Hostpital, between 1998 and 2002, were reviewed. The frequencies of hepatic enzyme elevation in association with clinical variables such as time course of the use of antipsychotics were analyzed . Results：Significant elevation in alanine aminotransferase (ALT) to upper reference range and 2 fold range were seen in olanzapine monotherapy patients, but not in risperidone monotherapy group. There was no difference between olanzapine and risperidone monotherapy groups in time course of hepatic dysfunction. There was no difference in hepatic enzyme elevation between resperidon and olanzapine combination therapy groups. Conclusion：The results suggest potential difference in degree of antipsychotic induced hepatic dysfunction between risperidone and olanzapine treatment. Well-desigend prospective study would be nessassary to extend our putative results.

목차

서 론

방 법

결 과

고 찰

결 론

REFERENCES

키워드

Hepatic enzyme elevation Risperidone Olanzapine